1Bryant ML,Bridges EG,Placidi L,et al.Antiviral L-nucleosides specific for hepatitis B virus infection.Antimicrob Agents Chemother,2001,45:229-235.
2Zhou XJ,Lloyd DM,Cbao GC,et al.Absence of food effect on the pharmacokinetics of telbivudine following oral administration in healthy subjects.J Clin Pharmacol,2006,46:275-281.
3Zhou XJ,Lim SG,Lloyd DM,et al.Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection:pharmacodynamic implications.Antimicrob Agents Chemother,2006,50:874-879.
4Lai,CL,Lim SG.A dose finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection.Hepatology,2004,40:719-726.
5Lai CL,Leung N,Teo EK,et al.A l-year trial of telbivudine,lamivudine,and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B.Gastroenterology,2005,129:528-536.
6Lai CL,Leung N,Teo EK,et al.Phase Ⅱb Extended-Treatment Trial of Telbivudine (LdT) vs.Lamivudine vs Combination Treatment in Hepatitis B Patients:Two-Year Results.DDW,Chicago,IL,USA.2005.
7Lai CL,Gane E,Thongsawat S,et al.Telbivudine (LdT) vs.Lamivudine in the treatment of Chronic Hepatitis B:Results from GLOBE,an international Phase Ⅲ TriaL.Shanghai-Hong Kong International Liver Congress; 2006.
8Lai CL,Gane E,Hsu CW,et al.Two-Year Results from the GLOBE Trial in Patients with Hepatitis B:Greater Clinical and Antiviral Efficacy for Telbivudine (LdT) vs Lamivudine.Hepatology,2006,44(4 Suppl 1):222A.
9Hou JL,Yin YK,Xu DZ,et al.A phase Ⅲ comparative trial of telbivudine and lamivudine for treatment of chronic hepatitis B in Chinese patients:first year results.Presented at:Shanghai-Hong Kong International Liver Congress; 2006.
10Bzowej N,Chan LYH,Lai CL,et al.A randomized trial of telbivudine(LdT) vs.adefovir for HBeAg-positive chronic hepatitis B:final week52 results.Hepatology,2006,44(4,Suppl 1):563A.
5Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931